Investment in Associates - Schedule of Fair Value of the Investment (Details) - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Schedule of Fair Value of the Investment [Abstract]
Balance at beginning	$ 591
Investment date March 31, 2022		700
Equity losses from investment in MitoCareX	(210)	(109)
Balance at ending	781	$ 591
Investment following achievement of first milestone	$ 400

The amount of financial assets that are measured at fair value through other comprehensive income. A financial asset shall be measured at fair value through other comprehensive income if both of the following conditions are met: (a) the financial asset is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets and (b) the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. [Refer: At fair value [member]; Financial assets]

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2024-01-01
-Paragraph 8
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_8_h&doctype=Standard
-URIDate 2024-03-27

Name:	ifrs-full_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant